These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24563542)

  • 41. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis.
    Tanaka K; Yu HA; Yang S; Han S; Selcuklu SD; Kim K; Ramani S; Ganesan YT; Moyer A; Sinha S; Xie Y; Ishizawa K; Osmanbeyoglu HU; Lyu Y; Roper N; Guha U; Rudin CM; Kris MG; Hsieh JJ; Cheng EH
    Cancer Cell; 2021 Sep; 39(9):1245-1261.e6. PubMed ID: 34388376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.
    Wang H; Zhang L; Yang X; Jin Y; Pei S; Zhang D; Zhang H; Zhou B; Zhang Y; Lin D
    Oncotarget; 2015 Jun; 6(16):14385-98. PubMed ID: 25965911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A coordinated action of Bax, PUMA, and p53 promotes MG132-induced mitochondria activation and apoptosis in colon cancer cells.
    Ding WX; Ni HM; Chen X; Yu J; Zhang L; Yin XM
    Mol Cancer Ther; 2007 Mar; 6(3):1062-9. PubMed ID: 17363499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.
    Kaestner P; Stolz A; Bastians H
    Mol Cancer Ther; 2009 Jul; 8(7):2046-56. PubMed ID: 19584233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Synergistic Anti-colon Cancer Effect of Aurora A Inhibitors and AKT Inhibitors Through PI3K/AKT Pathway.
    Sun C; Qu Z; Liu W; Qiu Z; Lü Y; Sun Z
    Anticancer Agents Med Chem; 2023; 23(1):87-93. PubMed ID: 35466883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspase-9 mediates Puma activation in UCN-01-induced apoptosis.
    Nie C; Luo Y; Zhao X; Luo N; Tong A; Liu X; Yuan Z; Wang C; Wei Y
    Cell Death Dis; 2014 Oct; 5(10):e1495. PubMed ID: 25356864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
    AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
    Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.
    Nordigården A; Kraft M; Eliasson P; Labi V; Lam EW; Villunger A; Jönsson JI
    Blood; 2009 Mar; 113(10):2302-11. PubMed ID: 19064725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737.
    Pétigny-Lechartier C; Duboc C; Jebahi A; Louis MH; Abeilard E; Denoyelle C; Gauduchon P; Poulain L; Villedieu M
    Mol Cancer Ther; 2017 Jan; 16(1):102-115. PubMed ID: 27980105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aurora-A kinase regulates NF-kappaB activity: lessons from combination studies.
    Linardopoulos S
    J BUON; 2007 Sep; 12 Suppl 1():S67-70. PubMed ID: 17935280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.
    Ambroise G; Portier A; Roders N; Arnoult D; Vazquez A
    Oncotarget; 2015 Nov; 6(35):38181-94. PubMed ID: 26431330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283.
    Curry J; Angove H; Fazal L; Lyons J; Reule M; Thompson N; Wallis N
    Cell Cycle; 2009 Jun; 8(12):1921-9. PubMed ID: 19440047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.
    Hata AN; Rowley S; Archibald HL; Gomez-Caraballo M; Siddiqui FM; Ji F; Jung J; Light M; Lee JS; Debussche L; Sidhu S; Sadreyev RI; Watters J; Engelman JA
    Oncogene; 2017 Nov; 36(47):6581-6591. PubMed ID: 28783173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells.
    Tsai MH; Liu JF; Chiang YC; Hu SC; Hsu LF; Lin YC; Lin ZC; Lee HC; Chen MC; Huang CL; Lee CW
    Oncotarget; 2017 Apr; 8(17):28342-28358. PubMed ID: 28423703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.
    Paller CJ; Wissing MD; Mendonca J; Sharma A; Kim E; Kim HS; Kortenhorst MS; Gerber S; Rosen M; Shaikh F; Zahurak ML; Rudek MA; Hammers H; Rudin CM; Carducci MA; Kachhap SK
    Cancer Med; 2014 Oct; 3(5):1322-35. PubMed ID: 24989836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA-dependent apoptosis in colorectal cancer.
    Chen J; Zhong J; Liu Y; Huang Y; Luo F; Zhou Y; Pan X; Cao S; Zhang L; Zhang Y; Wang J
    Cancer Med; 2018 Dec; 7(12):6158-6169. PubMed ID: 30402948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
    Hussain AR; Ahmed SO; Ahmed M; Khan OS; Al Abdulmohsen S; Platanias LC; Al-Kuraya KS; Uddin S
    PLoS One; 2012; 7(6):e39945. PubMed ID: 22768179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy.
    Tan S; Wei X; Song M; Tao J; Yang Y; Khatoon S; Liu H; Jiang J; Wu B
    Cell Death Dis; 2014 Mar; 5(3):e1128. PubMed ID: 24625987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263.
    Shao H; Jing K; Mahmoud E; Huang H; Fang X; Yu C
    Mol Cancer Ther; 2013 Dec; 12(12):2640-50. PubMed ID: 24126433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.